Efficacy of N-acetylcysteine vs dexamethasone in preventing postembolization syndrome post-transarterial chemoembolization in hepatocellular carcinoma: A randomized controlled trial

doi:10.3748/wjg.v31.i31.109630

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (395)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

HTML

124

Figures (1-3)

Tables (1-3)

Sum=211

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

126

Sum=164

Publishing Process of This Article

Item

Count

Browse

Download

Sum=6

Aug 21, 2025 (publication date) through Aug 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Controlled Trial

World J Gastroenterol. Aug 21, 2025; 31(31): 109630
Published online Aug 21, 2025. doi: 10.3748/wjg.v31.i31.109630

Full Size Figure Download Figure

Figure 1 Participant flow diagram. TACE: Transarterial chemoembolization; NAC: N-acetylcysteine; DEXA: Dexamethasone; HCC: Hepatocellular carcinoma; BCLC: Barcelona Clinic Liver Cancer.

Citation: Koonsiripaiboon P, Ruamtawee W, Simasingha N, Tanasoontrarat W, Claimon T, Sethasine S. Efficacy of N-acetylcysteine vs dexamethasone in preventing postembolization syndrome post-transarterial chemoembolization in hepatocellular carcinoma: A randomized controlled trial. World J Gastroenterol 2025; 31(31): 109630
URL: https://www.wjgnet.com/1007-9327/full/v31/i31/109630.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i31.109630